Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | UTS2R | Q9UKP6 | 7/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5069200 | 0.86 | RIPK1 (0.53) | AOC3MEN1KMT2ARIPK1HTT | |
| SCHEMBL1529441 | 0.86 | RIPK1 (0.53) | AOC3MEN1KMT2ARIPK1HTT | |
| SCHEMBL5065804 | 0.86 | RIPK1 (0.53) | AOC3MEN1KMT2ARIPK1HTT | |
| SCHEMBL15812308 | 0.85 | AOC3 (0.53) | AOC3MEN1KMT2A | |
| SCHEMBL5069163 | 0.83 | ADRB3 (0.41) | MEN1KMT2A | |
| SCHEMBL5065788 | 0.77 | ADRB2 (0.48) | AOC3MEN1KMT2AHTTL3MBTL1 | |
| SCHEMBL19399105 | 0.75 | AOC3 (0.51) | AOC3MEN1KMT2AUTS2RGAA | |
| SCHEMBL1530072 | 0.75 | CYP2C9 (0.41) | AOC3MEN1KMT2A | |
| SCHEMBL5454333 | 0.74 | AOC3 (0.58) | AOC3UTS2RL3MBTL1 | |
| SCHEMBL4688473 | 0.72 | POLB (0.40) | AOC3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318947-A1 | Inhibitors of Akt Activity | HEERDING DIRK A | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318947-A1 | Inhibitors of Akt Activity | PI4KB, PIK3CA, AKT2 | AOC3 4778/4885MEN1 3151/4885KMT2A 1852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.